XML 15 R5.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Cash Flows (Unaudited)
9 Months Ended
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Statement of Cash Flows [Abstract]    
Tenant Improvement Allowance Received from Landlord $ 3,094,000 $ 1,324,000
Cash flows from operating activities:    
Net income 13,826,000 21,979,000
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation (7,562,000) (6,577,000)
Amortization of capitalized software costs 6,626,000 7,428,000
Amortization of other intangibles 16,953,000 5,402,000
Amortization of debt issuance costs 807,301.88 0
Loss on disposal of equipment and improvements 452,000 158,000
Provision for bad debts 2,503,000 2,107,000
Provision for inventory obsolescence 369,000 118,000
Share-based compensation 5,177,000 2,328,000
Deferred income taxes 1,367,000 741,000
Change in fair value of contingent consideration 3,797,000 1,201,000
Loss on disposition of Hospital Solutions Division 0 1,366,000
Net cash provided by operating activities 81,423,000 27,292,000
Changes in assets and liabilities:    
Accounts receivable 16,005,000 11,313,000
Inventory (66,000) (160,000)
Accounts payable (5,983,000) 6,000
Deferred revenue (8,195,000) (10,320,000)
Accrued compensation and related benefits (50,000) (7,706,000)
Income taxes 18,060,000 (18,395,000)
Deferred compensation 381,000 917,000
Other assets and liabilities 1,832,000 2,232,000
Cash flows from investing activities:    
Additions to capitalized software costs (6,371,000) (11,604,000)
Proceeds from sales and maturities of marketable securities 9,291,000 5,310,000
Additions to equipment and improvements (8,242,000) (9,926,000)
Purchases of marketable securities 0 (6,024,000)
HealthFusion working capital adjustment payment 282,000 0
Net cash used in investing activities (5,604,000) (22,244,000)
Cash flows from financing activities:    
Principal repayments on line of credit (80,000,000) 0
Proceeds from issuance of shares under employee plans 999,000 732,000
Dividends paid 0 (32,125,000)
Net cash used in financing activities (79,001,000) (31,393,000)
Net increase decrease in cash and cash equivalents (3,182,000) (26,345,000)
Cash and cash equivalents at beginning of period 27,176,000 118,993,000
Cash and cash equivalents at end of period 23,994,000  
Cash paid for income taxes 4,455,000 27,653,000
Proceeds from Income Tax Refunds 19,932,000 2,079,000
Cash paid for interest 1,670,000 0
Dividends declared but not paid 0 10,726,000
Unpaid additions to equipment and improvements 0  
Common stock issued for Mirth share-based contingent consideration $ 9,273,000 $ 9,273,000